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The human insulin-like growth factor type 2 recep­
tor gene (IGF2R) is b iallelically expressed in a variety 
of fetal and adult tissues. In contrast, the imprinted 
mouse Igf2r  gene is expressed exclusively from the ma­
ternally inherited chromosome. The mouse gene con­
tains two CpG islands that are m ethylated in a parent- 
specific manner. M éthylation of the CpG island in the 
promoter region occurs on the repressed paternal 
gene copy. M éthylation of the CpG island in intron 2 
is specific for the active m aternal allele and may repre­
sent the primary im print. Here, we have analyzed the 
human IGF2R gene to investigate whether these motifs 
and their parent-of-origin-specific epigenetic modifi­
cation have been conserved. As in  the mouse, the hu­
man IGF2R gene was found to contain two CpG is­
lands, one encom passing the transcription start site 
(CpG 1) and the other in  the second intron (CpG 2). 
CpG 2 is hyperm ethylated on the maternal IGF2R al­
lele. In contrast to the situation in the mouse, however, 
the human CpG 1 is com pletely unmethylated on both 
parental chromosomes, The human and mouse in- 
tronic CpG islands lack significant sequence homol­
ogy* which suggests that DNA conformation plays a
role in  allele-Specific m éthylation. © 199B Academic Press, Inc.
INTRODUCTION
In mammals, certain genes show parent-specific ex­
pression in the embryo and in the adult because pater­
nal and maternal genomes are differentially modified, 
or imprinted, during male and female gametogenesis. 
Aberrant imprinting of genes or the deviation of both 
homologous chromosomes from one parent (uniparen­
tal disomy) can be the cause of genetic disorders (Hall, 
1990a,b; Clarke, 1990) and may also play a role in carci­
nogenesis (Wilkins, 1988; Sapienza, 1991, 1992; Reik,
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1992; Feinberg, 1993; Mariman et aL, 1995). At pres­
ent, the nature of the primary imprint and the molecu­
lar basis by which genes are recognized as paternally 
or maternally derived are still unknown. First evidence 
that méthylation plays an important role in genomic 
imprinting came from the observation that many 
transgenes become hypomethylated after passage 
through the male germline and hypermethylated after 
passage through the female germline (Surani et al,,
1988), Analysis of four imprinted genes in the mouse, 
H19 (Bartolomei et al., 1993; Ferguson-Smith et al, 
1993; Brandeis et al., 1993; Feil et al., 1994), insulin- 
like growth factor II {Igf2) (Sasaki et al, 1992; Bran­
deis et al., 1993; Feil et al., 1994), Igf2 receptor (Igf2r) 
(Stôger et alv 1993), and U2afl-rsl (SP2) (Hatada et 
al., 1995), has revealed that regions within the gene 
or adjacent to it are methylated in a parent-specific 
manner, The mouse Igf2r gene is expressed exclusively 
from the maternally inherited chromosome in fetal and 
adult tissues (Barlow et al., 1991), with the exception 
of the head and the brain, where biallelic expression 
has been observed (Villar and Pedersen, 1994). During 
preimplantation development, both maternal and pa­
ternal Igf2r alleles are expressed (Latham et al., 1994; 
Szabô and Mann, 1995), indicating that silencing of the 
paternal allele is a secondary event. Characterization 
of the mouse Igf2r gene revealed the existence of two 
distinct CpG islands that show parental-origin-specific 
méthylation differences. The first CpG island that in­
cludes the promoter (region 1) is methylated on the 
repressed paternal allele, whereas the intronic CpG 
island 27 kb downstream of the promoter (region 2) 
is methylated on the expressed maternal allele. The 
paternal-specific méthylation pattern of region 1 is ac­
quired after fertilization and is unchanged in the adult. 
Méthylation of region 2 is inherited through the female 
gamete and is maintained during preimplantation de­
velopment (Stoger et al, 1993). Therefore, it is thought 
to represent the primary imprinting signal. On the un­
methylated paternal allele, this region may act as a
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powerful “gene silencer’’ by binding an inhibitory factor 
(Stoger et al, 1993; Barlow, 1994). This model is sup­
ported by the recent finding that in the absence of DNA 
methylation, the otherwise active maternal Igf2r gene 
is repressed (Li et a l, 1993).
We (Kalscheuer et a l, 1993) and others (Ogawa et 
al, 1993) have recently shown that in contrast to the 
murine gene, the human IGF2R gene is expressed from 
both parental alleles in first and second trimester fe­
tuses, although in a minority of individuals mono allelic 
expression of the maternal allele has been reported (Xu 
et al, 1993). This raises the question whether differen­
tial imprinting in humans and mice is due to methyla­
tion differences. As reported here, we have isolated the 
human IGF2R gene, identified two intragenic CpG is­
lands, and found that one of these, but not the other, 
shows parent-specific methylation differences.
MATERIALS AND METHODS
YAC characterization and cosmid mapping, Screening of the ICI 
human YAC library was performed by PCR with primer pairs gener­
ated from the 5' and 3' ends of the human IGF2R cDNA sequence 
(Morgan et aL, 1987) (5' UTR: 16-1 AGTCGAGCCGCGCTCACCT, 
16-2 CTGCACAGCTCGGGGAACG; 3' UTR: 16-3 AATCATGGG- 
CCAGAGCCTCG, 16-4 GTTGAAATC AAAC AAG C C AG CCA). One
clone was positive for both sets of primers and was further analyzed. 
Yeast cultures were grown in selective synthetic medium lacking 
tryptophan and uracil, High-molecular-weight yeast DNA was pre­
pared in agarose plugs using standard protocols (Mueller and Wold, 
1989). For long-range restriction mapping, single and double diges­
tions were performed on the plugs with enzymes cutting infrequently 
in human DNA and analyzed by pulsed-field gel electrophoresis. 
DNA fragments were separated in 1.5% agarose with running condi­
tions at 150 V, 16°C for 38 h and transferred overnight by capillary 
blotting to GeneScreen Plus membranes. To visualize the specific 
YAC fragments, the filter was hybridized sequentially with probes 
generated from YAC right and left insert ends, 5' and 3' PCR frag­
ments, and total human DNA. Chimerism of the clone was excluded 
by FISH analysis on human metaphase chromosomes exactly as de­
scribed (Suijkerbuijk et aL, 1993).
To establish a cosmid library, YAC DNA was isolated according to 
Green and Olson (1990) and partially digested with SauSA  (New 
England Biolabs). Fragments were size fractionated by centrifuga­
tion through a sucrose gradient for 17 h? 22,000 rpm at 18°C. Size 
fractionated DNA of 30-45 kb (0.5 pg) was ligated into 1 pg of 
BamHI-digested SuperCos 1 vector (Stratagene) for 16 h at 16°C. 
Cosmid DNA was packaged using the Gigapack RII Gold packaging 
extract (Stratagene). Six thousand cosmid clones were screened with 
total human DNA, and 68 clones containing human DNA were grid- 
ded on GeneScreen Plus membranes and used for cosmid walking 
experiments. Hybridization and washing procedures were as de­
scribed elsewhere (Sambrook et a l, 1989). End clones of the human 
YAC insert were isolated by ligation-mediated PCR according to 
Mueller and Wold (1989). These probes, as well as the 5' and 3' PCR 
products amplified from genomic DNA, were used as starting points 
for cosmid walking and for generating the cosmid contig.
DNA sequence analysis. EcoRl fragments of cosmid C12 were 
subcloned into plasmid Bluescript or plasmid pT7T3. From these, 
clones containing CpG 1 and CpG 2 were further subcloned and 
sequenced using T3 and T7 primers and several CpG 1- or CpG 2- 
specific primers. Sequencing was performed using the T7 sequencing 
kit (Pharmacia), the Taq DyeDeoxy terminator cycle sequencing kit 
(Applied Biosystems), and the Taq track sequencing kit (Promega) 
in combination with terminal transferase as described by DeShazer
et al. (1994). Homology analyses were performed using the program 
FASTA, and sequences were aligned using the programs BESTFIT 
and GAP. CpG observed/expected ratios and C + G richness were 
calculated according to Gardiner-Garden and Frommer (1987), using 
the program CpGplot.
Oligo hybridization. Filters were prehybridized for at least 1 h 
at 50°C in 5x SSPE/0,3% SDS. Oligonucleotides (exon 1, ATGCGA- 
GCCGCGCTCACCT; exon 2, CATGGGAAGCTGTTGATACC; exon
3, CAACAGTGAGCTGTGACCAGCA; exon 4, ACTTTGAGTGGA- 
GGACCACTGC; exon 5, TGAGGAAGCATGATCTCAATCC; 3' UTR, 
AATCATGGGCCAGAGCCTCG) were phosphorylated using T4 poly­
nucleotide kinase (Gibco BRL) and [y-32PlATP and purified using 
Sephadex G50 (Pharmacia). Hybridization was for 3 h at 50°C under 
standard conditions (Sambrook et al., 1989). Filters were washed 
once with 2x SSC and twice with 5x SSPE/0.3% SDS at 50°C.
Methylation analysis with restriction enzymes. Twenty micro­
grams of genomic DNA derived from blood, liver, and placenta was 
digested with 100 U H ind lll (Gibco BRL) according to the manufac­
turer’s recommendations, extracted once with phenol/chloroform and 
once with chloroform, and precipitated with ethanol. The DNAs were 
divided into two portions and digested for 3 h with 50 U of either 
H pall or MspI (Gibco BRL), followed by a digestion with another 50 
U of the respective enzyme. The DNAs were then phenol extracted 
as described above and redigested with 50 U of H pall or M spl for 3 
h. For comparison of genomic and cosmid DNA digestion patterns, 
10 /¿g genomic DNA and 1 pg cosmid DNA were digested with 50 or 
5 U Hindlll^ respectively. After phenol extraction the DNAs were 
digested with methyl a ti on-sensitive enzymes (BssHII, Notl, Nrul, 
P vul, S a i l , Sm al, andX/ioI; Gibco BRL or New England Biolabs) as 
described above, Finally, the DNAs were ethanol precipitated and 
electrophoresed on a 1 to 1.5% agarose gel, transferred on a Gene­
Screen membrane, and hybridized with a 4.1-kb H ind lll fragment 
comprising CpG 1 and a 3-kb H ind lll fragment specific for CpG 2. 
Hybridization was performed at 65°C with random-primed labeled 
probes (Feinberg and Vogelstein, 1984). Filters were washed at 65°C 
with 2x SSC/0.1% SDS (15 min), IX SSC/0.1% SDS (15 min), and
0.1 X SSC/0.1% SDS (two times, each 15 min) successively. Autora­
diograms were exposed for 2 h to 2 weeks.
Bisulfite modification, PCR amplification, and sequencing. Geno­
mic DNA (10 pg) and cloned DNA (2 pg) were first digested with 
H ind lll and then alkaline denatured in 0.3 N  NaOH for 15 min at 
37°C. Treatment with sodium bisulfite was essentially as described 
by Clark et al. (1994). Modified DNAs were desalted and concentrated 
using GeneClean (Bio 101), ethanol precipitated, and resuspended in 
110 pi 100 mM  Tris-HCl (pH 8.0), 1 m M  EDTA. An aliquot of bisul­
fite-modified DNA was amplified by PCR under the following condi­
tions: initial denaturation for 5 min at 95°C, 1 min at 94°C, 2 min 
at 63°C, and 3 min at 72DC, for 35 cycles and then 6 min at 72°C. 
An aliquot was then reamplified using one additional internal
primer. CpG 1:16-34 CCCAATCRAACCRCRCTCACCTCRAACTCC- 
CRCT (944-977), 16-35 TTGTATAGTTYGGGGAAYGGGGYGGTT- 
TGGGTTT (1237-1204), 16-36 CRCRATTCCRAAACCRCCRCT- 
ACCRCTATCRCTAT (902-936); 16-48 AAAAAATCTAAAAAACTC- 
TAACRGAACCAAAATTA (436-469), 16-49 GYGATTGTTGGGGGT- 
YGTYGTTYGGGAYGGGGTYG (1043-1009), 16-50 RAACAATTA- 
AAATATATTCCCACCCCCCACRAATC (494-528); 16-52 GGAATA- 
AAGTAAATTGAGTTTTTGTTTTTAATTT (1609-1576), 16-51 TAA- 
AACCCRCRCCCRCCCRCCRCCCRCAACRCTC (1121-1154), 16-53 
TACTCCTACTACAACTACTACTACTCRTCRCTAC (1157-1190). 
CpG 2: 16-37 TTTTATTTGATTGGATTTTGGATTTTGTTATGTG 
(401-435), 16-38 AAAATAACCCAACCRCACRACCACRCTAAC- 
RACC (940-907), 16-39 TATTTTAGTTTYGTTTTTTAGTTTAGY- 
GTTTAGG (447-480); 16-40 GAGTTTTTTTGGGTTTTTTGTATT- 
TTTTTATGTT (1189-1222), 16-41AAACRAC A AAAC ATAC AAAAT - 
ACAAAAAAACRCRA (1549-1584), 16-42 TAYGATTTTTAGGTT- 
TTTYGYGTTTTTTTAGGGAT (1226-1259); 16-37, 16-39, 16-44 
AAACTCRAAAAACCAAAAAAACRCRAAAAACTAC (1194-1161); 
16-45 T AATCTATAAATTAAC AC ATA AC TC ACT AT AC RT (2156- 
2123), 16-46 ATGTTTYGTGTGY GTTGTTGTGTTTTAYGYGTT
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FIG. 1. The human 1GF2R locus. (A) A YAC containing the complete IGF2R gene (solid bar) is shown at the top. The minimal cosmid 
contig encompasses six cosmids. (B) Cosmid C12, which contains the 5* part of the gene including both CpG islands, is depicted in detail.
(1510-1142), 16-47 ACCATAAACTCRAAATAATAACTAATCCAA- 
TCCC (2122-2089); 16-41, 16-54 GGTTTTTGATATAGAGGGGTT- 
ATTTTATGTGTGA (1012-1045), 16-55 RCATAAAACACRAAA- 
AATACCRAATAATACAAA (1446-1478).
The resulting PCR fragments were phosphorylated using T4 poly­
nucleotide kinase and ligated into the Smal-digested plasmid vector 
pT7T3 19U (Pharmacia). Individual clones were sequenced using the 
T7 sequencing kit (Pharmacia).
RESULTS
Isolation of a YAC Clone Containing the Human
IGF2R Gene
To isolate a YAC clone containing the complete hu­
man IGF2R gene, we first generated STS primers using 
the published cDNA sequence of Morgan et al (1987). 
These primers, amplifying 290 bp of the 5'-untrans- 
lated region (UTR) and 324 bp of the 3' end of the 
IGF2R gene, were used to screen the human ICI YAC 
library by PCR. Three clones were isolated, one of 
which turned out to contain a human insert of 215 
kb comprising the complete IGF2R gene. As expected, 
FISH analysis on human metaphase chromosomes 
showed a hybridization signal at the telomeric region 
of the long arm of chromosome 6 (6q26) (not shown).
Single and double digestions of YAC DNA with re­
striction enzymes that cut infrequently in human DNA 
(jBssHII, Notl, Salí, M lul, and Sfil), followed by pulsed- 
field gel electrophoresis and Southern hybridization 
with human DNA, yielded the long-range restriction 
map shown in Fig, 1A. In a second step, a cosmid li­
brary was established, and a complete cosmid contig 
was constructed. Oligonucleotide hybridizations of
exon 1 and the 3' UTR to Southern blots of EcoRI- 
digested C12 and B12 cosmids enabled us to estimate 
the length of the gene as 140 kb and to determine its 
position within the YAC (Fig. 1A).
Two CpG Islands Are Present in the Hitman
IGF2R Gene
An 8.5-kb .EcoRI fragment containing the 5' part of 
the IGF2R gene was subcloned and partially se­
quenced. Sequence analysis comprised a 1.6-kb frag­
ment centered around exon 1 and revealed the exis­
tence of a CpG island (Figs. IB and 2A). This CpG 
island, termed CpG 1, spans the putative promoter re­
gion and extends into intron 1. The size of the pro­
moter-associated CpG islands of the human and mouse 
IGF2R genes is conserved. Three E-box-like sequences 
and several Spl boxes but no TATA or CAAT boxes 
were found in the region of 700 bp immediately up­
stream to exon 1 (not shown). Sequence comparison of 
the 5' end of the human and mouse IGF2R genes re­
vealed 71% homology between positions -700 and 
+455 bp of the human gene and positions -656 and 
+346 bp of the mouse gene (Accession Nos. X91875 and 
L06445). A similar degree of homology was found when 
the promoter region, exon 1, and intron 1 were ana­
lyzed separately.
Long-range restriction mapping revealed the pres­
ence of recognition sites for Notl and SssHII in a small 
region downstream from exon 2. A 6-kb EcoRI f r a g m e n t
of cosmid C12 (Fig. IB) was subcloned, and sequence 
analysis of 3 kb surrounding both restriction sites con-
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FIG. 2. Plots showing the G + C density (broken line) and CpG content (solid line) per 100 bp for a region of 1.8 kb encompassing CpG
1 (A) and a region of 3 kb encompassing CpG 2 (B). The data are expressed as the observed number of CpGs per 100 bp over the expected
number of CpGs per 100 bp. The diagrams display that CpG 1 and CpG 2 contain core sequences of approximately 1 and 1.3 kb. respectively 
that are more than 70% G + C. N, Notl, B, BssBll.
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firmed the presence of a second 1.3-kb-long CpG island, 
termed CpG 2 (Fig. 2B). Following successive hybrid­
izations of oligonucleotides specific for exons 1-4 to 
Southern blots of iJcoRI-digested C12 DNA, we were 
able to localize CpG 2 within intron 2. Comparison of 
CpG 2 and region 2 of the mouse Igf2r gene with the 
program BESTFIT displayed sequence homology of 
71% for a small segment of 38 bp starting at position 
1457 in the sequenced DNA fragment, including CpG 
2 and 1002 in region 2 (Accession Nos. X91880 and 
L06446). Analysis for repetitive elements within CpG 
2 showed four different tandem, direct repeats of 36,38, 
22, and 17 bp, respectively, with an overall homology of 
> 70% (Fig. 5C)? as well as a number of inverted repeats 
(not shown).
Despite the slightly different distances between CpG 
1 and CpG 2 (i.e., 27 kb in the mouse versus 40 kb in 
humans), the positions of these CpG islands within the 
gene have been conserved.
Methylation Analysis of CpG 1 and 2
In the mouse lgf2r gene, partial methylation of CpG 
sites in regions 1 and 2 has been found by Southern blot 
analyses of genomic DNA digested with methylation- 
sensitive restriction enzymes (Stoger et a l, 1993). To 
investigate methylation of the human gene, a 4.1-kb 
H indlll fragment comprising CpG 1 (probe 1, Fig. 3A) 
and a 3.0-kb H indlll fragment specific for CpG 2 (probe 
2, Fig. 4A) were used for Southern analyses of Mspl- or 
ifpall-digested human DNA isolated from peripheral 
blood. Following predigestion with Hmdlll, hybridiza­
tion of Mspl-digested control DNA with probe 1 re­
vealed fragments of 1.8 and/or 1.7 kb (due to an Mspl 
polymorphism), 0.8, and 0.4 kb (Fig. 3B, lane 1). Be­
cause of their small size, several other fragments could 
not be detected.
In ifpall-digested control DNA, the same probe 
showed one prominently hybridizing fragment of 2.6 
kb (Fig. 3B, lane 2), suggesting that the two Mspl/ 
HpaII sites in intron 1, marked by M* in Fig. 3A, are 
methylated, while other sites in this region are not. 
Fragments of 0.4 kb could be visualized only after 
longer exposure time (not shown).
The same Southern blot was used for methylation 
analysis of CpG 2. Mspl digestion yielded bands at 2.1 
and 0.4 kb (Fig. 4, lane 1) as well as several smaller 
fragments (not shown), ifpall-digested control DNA re­
sulted in a similar banding pattern, but in addition,
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FIG. 3, Methylation analysis of CpG 1. (A) The 4.1-kb Hmdlll 
(H) hybridization probe (probe 1) is shown, including CpG 1 and 
surrounding Mspl and/or H pall (M) sites; the asterisks refer to two 
Hpall sites. CpG 1 contains 22 Mspl sites that are not depicted here. 
The order of 0.8, 1,8> and 1.7 + 0.1 kb fragments is not exactly 
determined. (B) Southern blot analysis of control DNA, paternal, 
and maternal UPD DNA, digested with iim d lll and Mspl or H pall, 
after hybridization with the 4.1-kb H indlll fragment (probe 1) en­
compassing CpG 1. Weak signals at 3.0 and 2,1 kb are due to incom­
plete removal of the CpG 2 probe, which was applied first (Fig. 4),
zymes (BssHII, Notl, Nrul, Pvul, Sal I, Smal, andXfeoI) 
were employed to compare restriction patterns in (po­
tentially methylated) chromosomal DNA and (unmeth-
one prominent fragment of 3.0 kb was present (Fig. 4, ylated) DNA from cosmids spanning CpG 1 and CpG
lane 2), indicating that all Mspl restriction sites of this 
fragment that carry CpG 2 are resistant to digestion. 
Therefore, some of the DNA appears to be completely 
methylated at all Mspl recognition sites in CpG 2. Com­
parison of the methylation pattern of DNA isolated 
from peripheral blood, liver, and placenta all gave the 
same results (not shown). As an extension of this ap­
proach, other methylation-sensitive restriction en-
2, respectively. For CpG 1, banding patterns were iden­
tical in native and cloned DNA, which indicates that 
the respective CpGs are unmethylated in the genome. 
In contrast, a BssUll and a Notl restriction site in 
CpG2 were found to be partially methylated (not 
shown).
To study parental-allele-specific methylation in CpG
2, we analyzed DNA from peripheral blood of two pre-
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FIG. 4. Méthylation analysis of CpG2. (A) The 3.0-kb H indlll  
hybridization probe (probe 2) is shown. Vertical bars indicate MspU 
Hpall recognition sites; H indlll (H), Notl (N), and 5ssHII (B) are 
also depicted, (B) Southern blot of control, paternal, and maternal 
UPD DNA, after digestion with H indlll and MspI or Hpall and 
hybridization with probe 2.
viously described patients with uniparental disomy 
(UPD), one with unipaternal disomy and the other with 
unimaternal disomy for chromosome 6 (Welch et al.} 
1990; van den Berg-Loonen et al., submitted for publi­
cation).
CpG 1 Is Completely Unmethylated on Both Parental
IGF2R Alleles, and CpG 2 Is Methylated in a
Parent-Specific Manner
Since the above findings apply only to CpGs of partic­
ular restriction sites, the genomic sequencing tech­
nique developed by Frommer et al. (1992) was em­
ployed to determine the overall degree of méthylation 
in both CpG islands. In this method, sodium bisulfite 
quantitatively converts unmethylated cytosine to ura­
cil. This chemical modification is the basis for a PCR- 
based assay in which only methylated cytosines yield 
positive signals in DNA sequence ladders. After chemi­
cal modification, PCR fragments were cloned and se­
quenced. Analyses were performed on DNA from nor­
mal controls, including those isolated from fetal tissues 
with proven biallelic expression and from the patients 
with paternal and maternal uniparental disomy. In ad­
dition, cloned DNA was modified and used as a control 
to assess the efficiency and fidelity of the bisulfite reac­
tion and PCR amplifications. In all cases, our results 
showed that CpG 1 is hypomethylated on both parental 
chromosomes. Of the 138 CpGs in the promoter-associ­
ated CpG island, not a single one was methylated (not 
shown). In agreement with our previous restriction en­
zyme analysis, CpG 2 was found to be modified by 
méthylation in a parent-specific manner. DNA clones 
derived from maternal UPD DNA were methylated in 
most CpGs, while those derived from paternal DNA 
were hypomethylated. Méthylation patterns of individ­
ual clones from (non-UPD) control DNA showed a clear 
dichotomy, i.e., either almost complete méthylation or 
méthylation of only a few cytosine residues. Examples 
are shown in Figs. 5A and 5B. The méthylation status 
of three independent clones from paternal and mater­
nal UPD DNA is given in Fig. 5C.
Thus, our results clearly demonstrate that CpG 1 
of the human IGF2R gene is unmethylated on both 
parental alleles and that CpG 2 is modified in a parent-
DNA from both patients was digested with H indlll of-origin-specific manner, with the maternal locus be- 
and Mspl or Hpall, and Southern blots were hybridized hypermethylated and the paternal locus being hy- 
successively to probes 1 and 2. For probe 1, the same pomethylated. 
banding pattern as in control DNA was seen (Fig. 3B, 
lane 3), indicating that the Mspl/Hpall sites in intron 
1 (M*) are methylated on both parental chromosomes.
It is noteworthy that hybridization of probe 2 to Hpall- 
digested paternal UPD DNA showed a 3.0-kb band that 
is much fainter than that seen in control DNA (Fig.
DISCUSSION
4B, lane 4). This suggests that only very few paternal 
chromosomes are methylated at all MspUHpall sites 
in CpG 2. On the other hand, all of these sites must be
We have previously shown that in contrast to the 
mouse, the human IGF2R gene is equally expressed 
from both paternal and maternal alleles in various tis­
sues of first and second trimester fetuses, and this has 
since been confirmed in several additional cases. Fur­
thermore, both unimaternal and unipaternal disomy
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for the human IGF2R gene does not give rise to specific 
symptoms (Welch et a l, 1990; van den Berg-Loonen et 
al., submitted for publication). Biallelic expression of 
human 1GF2R in various tissues was also shown by 
Ogawa et al. (1993) and Xu et a l (1993). However, in 
lung and placenta of two fetuses, Xu et al. found that 
transcription was exclusively maternal, suggesting 
that in a small proportion of the human population 
the IGF2R gene may be monoallelically expressed. The 
expression pattern of the human IGF2R gene at earlier 
stages of development is still unknown. In the mouse, 
both maternal and paternal Igf2r alleles are expressed 
during preimplantation development (Latham et al., 
1994; Szabo and Mann, 1995), indicating that in this 
species, monoallelic expression is due to secondary in­
activation of one Igf2r gene copy. Along these lines, 
biallelic expression of the human IGF2R gene might 
result from failing repression of the paternal allele.
There is ample evidence that parental allele-specific 
méthylation plays a crucial role in genomic imprinting, 
The mouse Igf2 gene is hypermethylated on the ex­
pressed paternal allele (Sasaki et aL, 1992; Brandeis 
et al., 1993; Feil et al., 1994), and this méthylation is 
required for expression (Li et a l, 1993). The closely 
linked and reciprocally imprinted mouse H19 gene is 
methylated specifically on the repressed paternal chro­
mosome (Bartolomei et al., 1993; Ferguson-Smith et al., 
1993; Brandeis et al., 1993; Feil et aL, 1994). In addi­
tion, tissue-specific méthylation, directly proportional 
to the transcriptional levels, was found (Feil et al., 
1994). Analogous to the situation in the mouse, allelic 
méthylation differences are also present in the human 
IGF2 and H19 genes (Reik et aL, 1994; Zhang et aL, 
1993). One of the best studied imprinted genes in the 
mouse is the Igf2r gene. Two CpG-rich regions of the 
mouse Igf2r gene are modified by méthylation in a par- 
ent-of-origin-specific manner. Region 1, which contains 
the promoter, is methylated specifically on the re­
pressed paternal allele. Méthylation takes place during 
late development, probably after transcriptional re­
pression of the gene. In the gametes and in early em­
bryos, this region is unmethylated. In contrast, a sec­
ond CpG island within intron 2 is specifically methyl­
ated on the active maternal allele. Méthylation of this 
region is already present in the female gamete and 
remains unchanged during preimplantation develop­
ment and in the adult. Maternal méthylation of this 
region was proposed to represent the primary im­
printing signal for the mouse Igf2r gene (Stoger et al., 
1993; Barlow, 1994).
Here, we have shown that the human IGF2R gene, 
too, contains CpG islands that are located at comparable 
positions. CpG 1 extends from the promoter region into 
intron 1, and CpG 2 is situated in intron 2. Sequence 
comparison of the murine and human 5' CpG islands 
displayed 73 and 78% homology for the promoter region 
and the analyzed part of intron 1, respectively. Detailed 
méthylation analysis of all 138 CpGs across CpG 1 re-
A
vG
.O'
&
ir ir
G ATC G ATC G ATC
I
: . v 5 £ .  * * *
W  Î .life*-- •
r. « ■  ; : i mp*  :
■ (
r
*
Ul "■[ V;- r
• 1
***/ i
I
FIG. 5. Méthylation analysis of CpG 2 by genomic sequencing of 
individual maternal and paternal chromosomes and sequence analy­
sis for direct repeats and homology to the mouse Igf2r gene. Follow­
ing sodium-bisulfite modification of control (genomic), paternal, and 
maternal UPD DNA, nested PCR was performed. PCR products were 
cloned and sequenced. (A) An example of the segment of CpG 2 
amplified with the primer set 16-37/38 followed by 16-39/38. (B) The 
fragment amplified with the primer set 16-40/41 followed by 16-42/ 
41 (see Materials and Methods). As demonstrated by bands in the 
G-lanes, all CpGs were found to be methylated (dots and arrowheads) 
in genomic control and maternal UPD DNA, whereas in paternal 
UPD DNA most cytosine residues of CpGs are converted, indicating 
the presence of only a few methylated Cs (arrowheads). Aliquots of 
genomic control and maternal UPD DNA from the same bisulfite 
reaction were found to be completely converted at all cytosines of 
CpGs in CpG 1 (not shown). (C) Allele-specific méthylation of CpG
2, sequence analysis for direct repeats, and homology to region 2 of 
the mouse Igf2r gene. The méthylation data were compiled from a 
complete analysis of three individual sodium-bisulfite-modified pa­
ternal and maternal chromosomes. CpGs unmethylated in all three 
clones are shown as open circles; one of three methylated as 1/3 
black; two of three methylated as 2/3 black; and all three methylated 
as black circles. The horizontal line represents the chromosome; the 
paternal méthylation pattern is depicted above and the maternal 
pattern below this line. The nucleotides correspond to the positions 
of these fragments in the sequenced part of intron 2 (Accession No, 
X91880). Dots above the circles indicate Mspl and/or HpaH sites. 
N, Notl and B, BssHII restriction sites. The 38-bp fragment, 71% 
homologous to the mouse Igf2r gene, is shown by the black bar. 
Direct repeats with an overall homology of >70% are displayed by 
boxes, and sequence relationships within the repeats are represented 
by identical patterns.
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Indeed, analysis of CpG 2 showed the presence of a 
number of direct repeats that are specific for the human
vealed a complete lack of méthylation on both parental 
alleles. This is in marked contrast with the situation in 
the mouse, where region 1 is methylated on the repressed IGF2R gene. Thus, the human IGF2R gene resembles 
paternal allele. Therefore, our findings further substanti- other imprinted genes as far as monoparental methyla- 
ate a relation between promoter méthylation and tran- tion and repeats are concerned, but it is not monoalleli-
cally expressed.
It is increasingly clear that imprinted genes are dus- 
et aL, 1993), but this modification is possibly responsible tered in the genome. In the mouse, support for an im-
scriptional inactivity. Apparently, promoter méthylation 
does not precede the initial inactivation process (Stoger
for maintaining the silent state.
Sequence homology between CpG 2 and region 2 of 
the mouse Igf2r gene was found to be confined to a 
small segment of 38 bp. Thus, in contrast to the CpG 
island in the promoter region, the sequence of the in­
printed region on proximal chromosome 17 has come from 
the recent report that the Mas proto-oncogene, located 
less than 300 kb apart from the lgf2r gene, is imprinted 
in a developmental- and tissue-specific manner (Villar 
and Pedersen, 1994). MAS, the human homolog of the
tronic CpG island is not conserved. Still, as in the mouse Mas gene, is also located in the vicinity of the 
mouse, the intronic CpG island of the human IGF2R IGF2R locus on the distal long arm of chromosome 6
gene is methylated in a parent-specific manner. The 
paternal allele was clearly hypomethylated, whereas 
méthylation of the maternally derived allele was nearly 
complete. Thus, allele-specific méthylation of CpG 2 
has been conserved between human and mouse, but in 
humans, the link between parent-specific méthylation 
of CpG 2 and monoallelic expression seems to have 
been lost. Differences in chromatin structure as well
(Rabin et aL, 1987). The observation that paternal (Welch 
et aL, 1990) and maternal UPD 6 (van den Berg-Loonen 
et aL, submitted for publication) are compatible with nor­
mal human development supports our previous finding 
that the IGF2R gene is not imprinted (Kalscheuer et aL, 
1993) and raises the possibility that this holds for the 
MAS gene, too. Expression and methylation studies 
should soon clarify this point and may shed more light
as in the absence or presence of a trans-acting factor on the role of gene-specific and regional factors in the
acting as a repressor by binding to the hypomethylated control of parent-specific expression, 
paternal CpG 2 region may account for the differential
expression of the human and mouse IGF2R genes. ACKNOWLEDGMENTS
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